Hsbc Holdings PLC 23and Me Holding Co. Transaction History

Hsbc Holdings PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$0.36 - $0.61 $361 - $612	1,004 Added 3.09%	33,447 $13,000
Q1 2024 May 15, 2024	BUY	$0.4 - $0.91 $12,977 - $29,523	32,443 New	32,443 $17,000
Q3 2022 Nov 14, 2022	SELL	$2.6 - $5.12 $63,341 - $124,733	-24,362 Reduced 65.17%	13,022 $38,000
Q2 2022 Aug 11, 2022	BUY	$2.19 - $3.98 $29,096 - $52,878	13,286 Added 55.13%	37,384 $91,000
Q1 2022 May 16, 2022	BUY	$3.28 - $7.12 $79,041 - $171,577	24,098 New	24,098 $94,000
Q4 2021 Feb 11, 2022	SELL	$6.55 - $13.25 $81,043 - $163,942	-12,373 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$7.29 - $11.0 $90,199 - $136,103	12,373 New	12,373 $109,000

116

82.5M

404K

292K

Ticker ME
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 259,768,000
Market Cap $823M
Description
23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.